These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 30875336)

  • 1. Cost-effectiveness of second-line diagnostic investigations in patients included in the DANTE trial: a randomized controlled trial of lung cancer screening with low-dose computed tomography.
    Lopci E; Castello A; Morenghi E; Tanzi D; Cavuto S; Lutman F; Chiesa G; Vanni E; Alloisio M; Infante M
    Nucl Med Commun; 2019 May; 40(5):508-516. PubMed ID: 30875336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lung cancer screening with low-dose computed tomography: a non-invasive diagnostic protocol for baseline lung nodules.
    Veronesi G; Bellomi M; Mulshine JL; Pelosi G; Scanagatta P; Paganelli G; Maisonneuve P; Preda L; Leo F; Bertolotti R; Solli P; Spaggiari L
    Lung Cancer; 2008 Sep; 61(3):340-9. PubMed ID: 18308420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of Lung Cancer Screening in Canada.
    Goffin JR; Flanagan WM; Miller AB; Fitzgerald NR; Memon S; Wolfson MC; Evans WK
    JAMA Oncol; 2015 Sep; 1(6):807-13. PubMed ID: 26226181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis models to assess cost effectiveness of the four strategies for the work-up of solitary pulmonary nodules.
    Tsushima Y; Endo K
    Med Sci Monit; 2004 May; 10(5):MT65-72. PubMed ID: 15114278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trade-off between benefits, harms and economic efficiency of low-dose CT lung cancer screening: a microsimulation analysis of nodule management strategies in a population-based setting.
    Treskova M; Aumann I; Golpon H; Vogel-Claussen J; Welte T; Kuhlmann A
    BMC Med; 2017 Aug; 15(1):162. PubMed ID: 28838313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of lung lesion biopsies between low-dose CT-guided and conventional CT-guided techniques.
    Meng XX; Kuai XP; Dong WH; Jia NY; Liu SY; Xiao XS
    Acta Radiol; 2013 Oct; 54(8):909-15. PubMed ID: 23817682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lung cancer probability in patients with CT-detected pulmonary nodules: a prespecified analysis of data from the NELSON trial of low-dose CT screening.
    Horeweg N; van Rosmalen J; Heuvelmans MA; van der Aalst CM; Vliegenthart R; Scholten ET; ten Haaf K; Nackaerts K; Lammers JW; Weenink C; Groen HJ; van Ooijen P; de Jong PA; de Bock GH; Mali W; de Koning HJ; Oudkerk M
    Lancet Oncol; 2014 Nov; 15(12):1332-41. PubMed ID: 25282285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of indeterminate pulmonary nodules detected in lung cancer screening: Diagnostic accuracy of FDG PET/CT.
    Garcia-Velloso MJ; Bastarrika G; de-Torres JP; Lozano MD; Sanchez-Salcedo P; Sancho L; Nuñez-Cordoba JM; Campo A; Alcaide AB; Torre W; Richter JA; Zulueta JJ
    Lung Cancer; 2016 Jul; 97():81-6. PubMed ID: 27237032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can lung cancer screening by computed tomography be effective in areas with endemic histoplasmosis?
    Starnes SL; Reed MF; Meyer CA; Shipley RT; Jazieh AR; Pina EM; Redmond K; Huffman LC; Pandalai PK; Howington JA
    J Thorac Cardiovasc Surg; 2011 Mar; 141(3):688-93. PubMed ID: 20933243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-dose computed tomography for lung cancer screening in high-risk populations: a systematic review and economic evaluation.
    Snowsill T; Yang H; Griffin E; Long L; Varley-Campbell J; Coelho H; Robinson S; Hyde C
    Health Technol Assess; 2018 Nov; 22(69):1-276. PubMed ID: 30518460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of implementing computed tomography screening for lung cancer in Taiwan.
    Yang SC; Lai WW; Lin CC; Su WC; Ku LJ; Hwang JS; Wang JD
    Lung Cancer; 2017 Jun; 108():183-191. PubMed ID: 28625633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of hybrid PET/CT for staging of non-small cell lung cancer.
    Schreyögg J; Weller J; Stargardt T; Herrmann K; Bluemel C; Dechow T; Glatting G; Krause BJ; Mottaghy F; Reske SN; Buck AK
    J Nucl Med; 2010 Nov; 51(11):1668-75. PubMed ID: 21051648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current estimate of costs of lung cancer screening in the United States.
    Mauchley DC; Mitchell JD
    Thorac Surg Clin; 2015 May; 25(2):205-15. PubMed ID: 25901564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of FDG-PET/CT for cytologically indeterminate thyroid nodules: a decision analytic approach.
    Vriens D; Adang EM; Netea-Maier RT; Smit JW; de Wilt JH; Oyen WJ; de Geus-Oei LF
    J Clin Endocrinol Metab; 2014 Sep; 99(9):3263-74. PubMed ID: 24873995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of CT screening in the National Lung Screening Trial.
    Black WC; Gareen IF; Soneji SS; Sicks JD; Keeler EB; Aberle DR; Naeim A; Church TR; Silvestri GA; Gorelick J; Gatsonis C;
    N Engl J Med; 2014 Nov; 371(19):1793-802. PubMed ID: 25372087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-dose chest computed tomography for lung cancer screening among Hodgkin lymphoma survivors: a cost-effectiveness analysis.
    Wattson DA; Hunink MG; DiPiro PJ; Das P; Hodgson DC; Mauch PM; Ng AK
    Int J Radiat Oncol Biol Phys; 2014 Oct; 90(2):344-53. PubMed ID: 25104066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term Oncologic and financial implications of lung cancer screening.
    Pedersen JH; Sørensen JB
    Thorac Surg Clin; 2015 May; 25(2):223-9. PubMed ID: 25901566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of baseline low-dose computed tomography screening for lung cancer: the Israeli experience.
    Shmueli A; Fraifeld S; Peretz T; Gutfeld O; Gips M; Sosna J; Shaham D
    Value Health; 2013; 16(6):922-31. PubMed ID: 24041342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early lung cancer detection using spiral computed tomography and positron emission tomography.
    Bastarrika G; García-Velloso MJ; Lozano MD; Montes U; Torre W; Spiteri N; Campo A; Seijo L; Alcaide AB; Pueyo J; Cano D; Vivas I; Cosín O; Domínguez P; Serra P; Richter JA; Montuenga L; Zulueta JJ
    Am J Respir Crit Care Med; 2005 Jun; 171(12):1378-83. PubMed ID: 15790860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cost-effectiveness of PET in the management algorithms of lung tumors: comparison of health economic data].
    Dietlein M; Moka D; Weber K; Theissen P; Schicha H
    Nuklearmedizin; 2001 Aug; 40(4):122-8. PubMed ID: 11556202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.